Most GDUFA Rates Coming by Oct. 31, ANDA Filers to Pay About $50K

Washington Drug Letter
A A
Generic-drug makers, including those with backlogged ANDAs and companies submitting prior approval supplements (PASs) and drug master files (DMFs), will know how much user fee money they’ll have to dole out to the FDA in fiscal 2013 by the end of October.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00